These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32377814)

  • 1. Liver extracellular volume fraction values obtained with magnetic resonance imaging can quantitatively stage liver fibrosis: a validation study in monkeys with nonalcoholic steatohepatitis.
    Lyu L; Liu XL; Rui MP; Yang LC; Wang GZ; Fan D; Wang T; Zheng J
    Eur Radiol; 2020 Oct; 30(10):5748-5757. PubMed ID: 32377814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Combination of MR Elastography and Proton Density Fat Fraction Improves Diagnosis of Nonalcoholic Steatohepatitis.
    Alsaqal S; Hockings P; Ahlström H; Gummesson A; Hedström A; Hulthe J; Johansson L; Niessen HG; Schoelch C; Schultheis C; Vessby J; Wanders A; Rorsman F; Ebeling Barbier C
    J Magn Reson Imaging; 2022 Aug; 56(2):368-379. PubMed ID: 34953171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gd-EOB-DTPA-enhanced T1ρ imaging vs diffusion metrics for assessment liver inflammation and early stage fibrosis of nonalcoholic steatohepatitis in rabbits.
    Xie Y; Zhang H; Jin C; Wang X; Wang X; Chen J; Xu Y
    Magn Reson Imaging; 2018 May; 48():34-41. PubMed ID: 29278765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity.
    Pavlides M; Banerjee R; Tunnicliffe EM; Kelly C; Collier J; Wang LM; Fleming KA; Cobbold JF; Robson MD; Neubauer S; Barnes E
    Liver Int; 2017 Jul; 37(7):1065-1073. PubMed ID: 27778429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A comparative study of 3.0T (1)H-MRS for varying degrees of liver fibrosis in cynomolgus monkeys].
    Ding K; Liu MR; Huang RS; Lu SJ; Wei X; Wei XX
    Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):766-772. PubMed ID: 33053977
    [No Abstract]   [Full Text] [Related]  

  • 6. MR elastography is effective for the non-invasive evaluation of fibrosis and necroinflammatory activity in patients with nonalcoholic fatty liver disease.
    Costa-Silva L; Ferolla SM; Lima AS; Vidigal PVT; Ferrari TCA
    Eur J Radiol; 2018 Jan; 98():82-89. PubMed ID: 29279175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of MRI-derived liver surface nodularity score for the non-invasive quantification of hepatic fibrosis in non-alcoholic fatty liver disease.
    Catania R; Furlan A; Smith AD; Behari J; Tublin ME; Borhani AA
    Eur Radiol; 2021 Jan; 31(1):256-263. PubMed ID: 32757050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of liver surface nodularity quantification program and its clinical application in nonalcoholic fatty liver disease.
    Kim TH; Kim JE; Ryu JH; Jeong CW
    Sci Rep; 2019 Jul; 9(1):9994. PubMed ID: 31292497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR elastography in nonalcoholic fatty liver disease: inter-center and inter-analysis-method measurement reproducibility and accuracy at 3T.
    Tang A; Dzyubak B; Yin M; Schlein A; Henderson WC; Hooker JC; Delgado TI; Middleton MS; Zheng L; Wolfson T; Gamst A; Loomba R; Ehman RL; Sirlin CB
    Eur Radiol; 2022 May; 32(5):2937-2948. PubMed ID: 34928415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing liver fibrosis in chronic hepatitis B using MR extracellular volume measurements: Comparison with serum fibrosis indices.
    Wang HQ; Jin KP; Zeng MS; Chen CZ; Rao SX; Ji Y; Fu CX; Sheng RF
    Magn Reson Imaging; 2019 Jun; 59():39-45. PubMed ID: 30849483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Nonalcoholic Fatty Liver Disease in Rats Using Quantitative Dynamic Contrast-Enhanced MRI.
    Wu Z; Cheng ZL; Yi ZL; Xie MW; Zeng H; Lu LJ; Xu X; Shen J
    J Magn Reson Imaging; 2017 May; 45(5):1485-1493. PubMed ID: 27606822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic Alanine Differentiates Nonalcoholic Steatohepatitis From Simple Steatosis in Humans and Mice: A Proton MR Spectroscopy Study With Long Echo Time.
    Kim TH; Jun HY; Kim KJ; Lee YH; Lee MS; Choi KH; Yun KJ; Jeong YY; Jun CH; Cho EY; Yoon KH
    J Magn Reson Imaging; 2017 Nov; 46(5):1298-1310. PubMed ID: 28225569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive Assessment of Advanced Fibrosis Based on Hepatic Volume in Patients with Nonalcoholic Fatty Liver Disease.
    Hayashi T; Saitoh S; Fukuzawa K; Tsuji Y; Takahashi J; Kawamura Y; Akuta N; Kobayashi M; Ikeda K; Fujii T; Miyati T; Kumada H
    Gut Liver; 2017 Sep; 11(5):674-683. PubMed ID: 28651300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inter-reader agreement of magnetic resonance imaging proton density fat fraction and its longitudinal change in a clinical trial of adults with nonalcoholic steatohepatitis.
    Hooker JC; Hamilton G; Park CC; Liao S; Wolfson T; Dehkordy SF; Hong CW; Mamidipalli A; Gamst A; Loomba R; Sirlin CB
    Abdom Radiol (NY); 2019 Feb; 44(2):482-492. PubMed ID: 30128694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased severity of liver fat content and liver fibrosis in non-alcoholic fatty liver disease correlate with epicardial fat volume in type 2 diabetes: A prospective study.
    Brouha SS; Nguyen P; Bettencourt R; Sirlin CB; Loomba R
    Eur Radiol; 2018 Apr; 28(4):1345-1355. PubMed ID: 29058029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    Eddowes PJ; Sasso M; Allison M; Tsochatzis E; Anstee QM; Sheridan D; Guha IN; Cobbold JF; Deeks JJ; Paradis V; Bedossa P; Newsome PN
    Gastroenterology; 2019 May; 156(6):1717-1730. PubMed ID: 30689971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of MR-based texture analysis for the assessment of hepatic fibrosis in patients with nonalcoholic fatty liver disease (NAFLD).
    Cannella R; Borhani AA; Tublin M; Behari J; Furlan A
    Abdom Radiol (NY); 2019 May; 44(5):1816-1824. PubMed ID: 30788556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver surface nodularity on non-contrast MRI identifies advanced fibrosis in patients with NAFLD.
    Dioguardi Burgio M; Sartoris R; Beaufrere A; Grégory J; Guiu B; Guillot C; Rautou PE; Castera L; Bouattour M; Paradis V; Vilgrain V; Ronot M
    Eur Radiol; 2022 Mar; 32(3):1781-1791. PubMed ID: 34533606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated Analysis of Multiparametric Magnetic Resonance Imaging/Magnetic Resonance Elastography Exams for Prediction of Nonalcoholic Steatohepatitis.
    Dzyubak B; Li J; Chen J; Mara KC; Therneau TM; Venkatesh SK; Ehman RL; Allen AM; Yin M
    J Magn Reson Imaging; 2021 Jul; 54(1):122-131. PubMed ID: 33586159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on diagnostic value of extracellular volume imaging by magnetic resonance imaging for liver fibrosis of hepatitis B].
    Sheng RF; Jin KP; Wang HQ; Ji Y; Chen CZ; Zeng MS
    Zhonghua Gan Zang Bing Za Zhi; 2018 Sep; 26(9):650-653. PubMed ID: 30481860
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.